Quadrant Capital Group’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Quadrant Capital Group’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-690	Closed	-$24.1K	–	2807
2024 Q1	$24.1K	Hold	690	–	–	﹤0.01%	1764
2023 Q4	$26.2K	Buy	+690	New	+$14.8K	﹤0.01%	1691

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Quadrant Capital Group's INBX Position: Q2 2024 in Review

Quadrant Capital Group sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 690 shares — an estimated $24.1K sold.

Quadrant Capital Group first reported a position in INBX in Q4 2023 and held it in 2 quarters. The position peaked at $26.2K in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Quadrant Capital Group reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Quadrant Capital Group sold 690 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $24.1K.
Quadrant Capital Group first reported a position in Inhibrx, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
Quadrant Capital Group's Inhibrx, Inc. Common Stock position peaked at $26.2K in Q4 2023.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Quadrant Capital Group's 13F filing for Q2 2024, filed 12 Aug 2024.